Accessing GLP-1 treatment in San Mateo, California has traditionally meant longer waits than mainland patients face. Zepbound® is the FDA-approved Injectable pen Tirzepatide product by Eli Lilly. Weight Method's telehealth model is a separate program built for distance: licensed providers evaluate eligibility, and compounded Tirzepatide (dispensed by a U.S.-licensed 503A pharmacy) ships to any San Mateo address at $329/month. Compounded Tirzepatide is not FDA-approved.
FDA-approved Zepbound prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · San Mateo is already seeing results
Zepbound in San Mateo, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Zepbound to patients in San Mateo from $329/month with virtual consultations and direct-to-door shipping.
Tirzepatide targets the biological mechanisms involved in sustained weight regulation. By activating GLP-1 receptors in the brain, it can reduce hunger signals and slow gastric emptying. Eli Lilly developed Zepbound® as the FDA-approved Injectable pen product, taken Once weekly, approved in 2023. Weight Method is a separate program: licensed providers in California evaluate eligible patients via telehealth and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program for eligible San Mateo, CA residents starts at $329/month.
San Mateo is home to a large and vibrant Hispanic community, and Weight Method is committed to providing culturally competent care. Our bilingual providers understand the dietary traditions, family dynamics, and health concerns common in Hispanic households — and they deliver consultations in English or Spanish. Weight Method prescribes compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. Tirzepatide does not require abandoning cultural foodways; it works by reducing appetite so you naturally eat smaller portions of the foods you love.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in California and start Zepbound from $329/month.
Get Started NowFree consultation. No commitment.